A genome-wide association study of respiratory syncytial virus infection severity in infants
<p><strong>Background</strong></p> Respiratory syncytial virus (RSV) is a significant cause of infant morbidity and mortality worldwide. Most children experience at least one 1 RSV infection by the age of two 2 years, but not all develop severe disease. However, the understan...
主要な著者: | Johnson, M, Chelysheva, I, Öner, D, McGinley, J, Lin, G-L, O'Connor, D, Robinson, H, Drysdale, SB, Gammin, E, Vernon, S, Muller, J, Wolfenden, H, Westcar, S, Anguvaa, L, Thwaites, RS, Bont, L, Wildenbeest, J, Martinón-Torres, F, Aerssens, J, Openshaw, PJM, Pollard, AJ |
---|---|
その他の著者: | PROMISE Investigators |
フォーマット: | Journal article |
言語: | English |
出版事項: |
Oxford University Press
2024
|
類似資料
-
A systematic review and meta-analysis of animal studies investigating the relationship between serum antibody, T lymphocytes, and respiratory syncytial virus disease
著者:: McGinley, J, 等
出版事項: (2021) -
Single-cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants
著者:: Zivanovic, N, 等
出版事項: (2023) -
Clinical and viral factors associated with disease severity and subsequent wheezing in infants with respiratory syncytial virus infection
著者:: McGinley, JP, 等
出版事項: (2022) -
Presumed risk factors and biomarkers for severe respiratory syncytial virus disease and related sequelae: Protocol for an observational multicenter, case-control study from the Respiratory Syncytial Virus Consortium in Europe (RESCEU)
著者:: Jefferies, K, 等
出版事項: (2020) -
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
著者:: Salaun, B, 等
出版事項: (2023)